Live Breaking News & Updates on National Malaria Prevention
Stay updated with breaking news from National malaria prevention. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Author summary Why was this study done? Radical cure with primaquine or recently approved tafenoquine is required to clear the dormant liver parasites of vivax malaria. While single-dose tafenoquine overcomes the barrier of patient adherence to the current 7-day primaquine treatment, it costs more and requires screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency. While the impact of changing policies to tafenoquine after G6PD screening on transmission has been evaluated, the associated costs and cost-effectiveness will be important considerations for policymakers. What did the researchers find? Using an economic evaluation model coupled with a transmission model, we found that prescribing tafenoquine to vivax malaria patients without G6PD deficiency would be highly likely to be cost-effective in Brazil. Tafenoquine will be particularly cost-effective in settings where patient adherence to the current 7-day treatment is low and when paediatric tafenoquine is available ....
Vietnam targets end of malaria by 2030 – Talk Vietnam talkvietnam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from talkvietnam.com Daily Mail and Mail on Sunday newspapers.
Brazil reports decrease in malaria - Outbreak News Today outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.